Acorda Therapeutics Inc [ACOR]
$6.90 0.01 (0.15%)
Market Cap 330 Million
Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders.Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.
EPS -1.00 P/E Ratio 0.00
Previous Earnings Thu, May 2, 2019
Latest Earnings Thu, Aug 1, 2019 (In 11 days)
Pay Date --
|Symbol||Price||Day %||YTD %|
This list of trending stocks may change throughout the trading day.